Abstract
The long noncoding RNA TINCR shows aberrant expression in human squamous carcinomas. However, its expression and function in gastric cancer remain unclear. We report that TINCR is strongly upregulated in human gastric carcinoma (GC), where it was found to contribute to oncogenesis and cancer progression. We also revealed that TINCR overexpression is induced by nuclear transcription factor SP1. Silencing TINCR expression inhibited cell proliferation, colony formation, tumorigenicity and apoptosis promotion, whereas TINCR overexpression promoted cell growth, as documented in the SGC7901 and BGC823 cell lines. Mechanistic analyses indicated that TINCR could bind to STAU1 (staufen1) protein, and influence KLF2 mRNA stability and expression, then KLF2 regulated cyclin-dependent kinase genes CDKN1A/P21 and CDKN2B/P15 transcription and expression, thereby affecting the proliferation and apoptosis of GC cells. Together, our findings suggest that TINCR contributes to the oncogenic potential of GC and may constitute a potential therapeutic target in this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hanahan D, Weinberg RA . The hallmarks of cancer. Cell 2000; 100: 57–70.
Gutschner T, Diederichs S . The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012; 9: 703–719.
Muers M . RNA: genome-wide views of long non-coding RNAs. Nat Rev Genet 2011; 12: 742.
Ponting CP, Oliver PL, Reik W . Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629–641.
Ravasi T, Suzuki H, Pang KC, Katayama S, Furuno M, Okunishi R et al. Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res 2006; 16: 11–19.
Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS . Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 2008; 105: 716–721.
Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A Long Noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 947–947.
Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311–1323.
Pibouin L, Villaudy J, Ferbus D, Muleris M, Prosperi MT, Remvikos Y et al. Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 2002; 133: 55–60.
Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S . Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 2006; 25: 135–141.
Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007; 12: 215–229.
Lin R, Maeda S, Liu C, Karin M, Edgington TS . A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007; 26: 851–858.
Wan DF, Gong Y, Qin WX, Zhang PP, Li JJ, Wei L et al. Large-scale cDNA transfection screening for genes related to cancer development and progression. Proc Natl Acad Sci USA 2004; 101: 17565–17565.
Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 2013; 493: 231–U245.
Kim YK, Furic L, DesGroseillers L, Maquat LE . Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. Cell 2005; 120: 195–208.
Gong CG, Maquat LE . ALUstrious long ncRNAs and their roles in shortening mRNA half-lives. Cell Cycle 2011; 10: 1882–1883.
Gong CG, Maquat LE . lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 2011; 470: 284.
Cho H, Kim KM, Han S, Choe J, Park SG, Choi SS et al. Staufen1-mediated mRNA decay functions in adipogenesis. Mol Cell 2012; 46: 495–506.
Kim YK, Furic L, Parisien M, Major F, DesGroseillers L, Maquat LE . Staufen1 regulates diverse classes of mammalian transcripts. EMBO J 2007; 26: 2670–2681.
Black AR, Black JD, Azizkhan-Clifford J . Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001; 188: 143–160.
Kaczynski J, Cook T, Urrutia R . Sp1-and Kruppel-like transcription factors. Genome Biol 2003; 4: 206.
Wang F, Zhu Y, Huang Y, McAvoy S, Johnson WB, Cheung TH et al. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene 2005; 24: 3875–3885.
Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang XH, Farrar WL . Genomic profiling of tumor initiating prostatospheres. BMC Genomics 2010; 11: 324.
Taniguchi H, Jacinto FV, Villanueva A, Fernandez AF, Yamamoto H, Carmona FJ et al. Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene 2012; 31: 1988–1994.
Wu JH, Lingrel JB . KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Oncogene 2004; 23: 8088–8096.
Sherr CJ, Roberts JM . CDK inhibitors: positive and negative regulators of G(1)-phase progression. Genes Dev 1999; 13: 1501–1512.
Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K et al. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014.
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin L et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol 2014; 7: 63.
Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer 2014; 14: 319.
Zhuang M, Gao W, Xu J, Wang P, Shu Y . The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; 448: 315–322.
Sun M, Xia R, Jin F, Xu T, Liu Z, De W et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol 2014; 35: 1065–1073.
Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 2003; 9: 6371–6380.
Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu T-T et al. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 2004; 10: 4109–4117.
Sherr CJ, Roberts JM . Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149–1163.
Zhang SZ, Pan FY, Xu JF, Yuan J, Guo SY, Dai G et al. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol Cancer Ther 2005; 4: 1577–1584.
Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689–693.
Martianov I, Ramadass A, Barros AS, Chow N, Akoulitchev A . Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007; 445: 666–670.
Sun M, Liu XH, Li JH, Yang JS, Zhang EB, Yin DD et al. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther 2012; 11: 842–852.
Acknowledgements
We thank Dr Taniguchi (First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan) for the kind gift of KLF2-FLAG expression vector, Dr Wei-liang Xiong (Department of Biochemistry and The Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University) for the help of RNA pull down assay, and Professor Wei De and Dr Ming Sun (Department of Biochemistry and Molecular Biology, Nanjing Medical University) for the help of assay design. This study was supported by the National Natural Science Foundation of China (81172140, 81272532), Jiangsu Province Clinical Science and Technology projects (Clinical Research Center, BL2012008) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine, JX10231801).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Xu, Tp., Liu, Xx., Xia, R. et al. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene 34, 5648–5661 (2015). https://doi.org/10.1038/onc.2015.18
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2015.18
This article is cited by
-
Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma
BMC Bioinformatics (2023)
-
LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA
Gastric Cancer (2023)
-
The potential roles of lncRNA TINCR in triple negative breast cancer
Molecular Biology Reports (2023)
-
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma
Nature Communications (2023)
-
SIX5-activated LINC01468 promotes lung adenocarcinoma progression by recruiting SERBP1 to regulate SERPINE1 mRNA stability and recruiting USP5 to facilitate PAI1 protein deubiquitylation
Cell Death & Disease (2022)